Dr Joanne Lee is a consultant from the Department of Haematology-Oncology at the National University Cancer Institute, Singapore (NCIS). After receiving her undergraduate medical degree from the National University of Singapore (NUS), she continued her internal medicine training in the National University Health System Residency Programme where she obtained her post-graduate qualification from the Royal College of Physician, United Kingdom, and her Masters of Medicine (Internal Medicine) from NUS. She continued with her advanced specialty training in Haematology at NCIS, serving as the Chief Resident for Haematology, and obtaining her Fellowship of the Royal College of Pathologist, United Kingdom.
Her clinical and research interests are in lymphoma and haematopoietic stem cell transplant where she is actively involved in investigator initiated and pharmaceutical sponsored trials, and where she serves as the Lymphoma Group Lead in NCIS. She continues to be active in both undergraduate and postgraduate training for haematology and is currently an assistant professor with the Department of Medicine in NUS Yong Loo Lin School of Medicine, as well as a Core Faculty for the Haematology Senior Residency Programme in the National University Hospital.
1. "An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma" Science Translational Medicine Oct 2022. Goh J, de Mel S, Hoppe MM, Rashid M, Zhang XY, Jaynes P, Ng E, Rahmat NADB, Jayalakshmi, Liu XC, Poon LM, Chan HLE, Lee J, Chee YL, Koh LP, Tan LK, Soh TG, Yuen YC, Loi HY, Ng SB, Goh XY, Eu D, Loh S, Ng S, Tan D, Cheah D, Pang WL, Huang D, Ong SY, Nagarajan C, Chan J, Ha J, Khoo LP, Somasundaram N, Tang T, Ong CK, Chng WJ, Lim ST, Chow EK, Jeyasekharan AD.
2. "Central Nervous System (CNS) prophylaxis in antiCD20-CHOP treated DLBCL at intermediate to high risk for CNS relapse: A systematic review and meta-analysis" Critical Reviews in Oncology / Hematology Oct 2021. Ho GY, Tan C, de Mel S, Poon LM, Chan HLE, Lee J, Liu X, Chng WJ, Chee YL, Soon YY, Jeyasekharan AD.
3. "The RUNX1 Database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy" Haematologica. July 2021. Homan CC, King-Smith SL, Lawrence DM, Arts P, Feng JH, Andrews J, Armstrong M, Ha T, Dobbins J, Drazer MW, Yu K, Bodor C, Cantor A, Cazzola M, Degelman E, DiNardo CD, Duployez N, Favier Rm Frohling S, Fitzgibbon J, Klco JM, Kramer A, Kurokawa M, Lee J, aMalcovati L, Morgan NV, Natsoulis G, Owen C, Patel KP, Preudhomme C, Raslova H, Rienhoff H, Ripperger T, Schulte R, Tawana K, Velloso E, Yan B, Liu P, Godley LA, Schreiber AW, Hahn CN, Scott HS, Brown AL.
4. "Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in Cancer" Cancers. March 2020. Ngoi NYL, Choong C, Lee J, Bellot G, Wong ALA, Goh BC, Pervaiz S.
5. "Clincial Impact of the Cell-of-Origin (COO) Classification based on Immunohistochemistry criteria (IHC) and Lymph2Cx of Diffuse Large B-cell Lymphoma (DLBCL) patients in a Southeast Asian population: A single centre experience and review of the literature" Expert Review of Hematology. October 2019. Lee J, Hue SSS, Ko SQ, Tan SY, Liu X, Girard LP, Chan EHL, de Mel S, Jeyasekharan AD, Chee YL, Koh LP, Poon LM.
6. "A novel JAK2 R564* variant in a patient with thrombocytosis" International Journal of Laboratory Hematology. July 2019. Villanueva A, Poon KS, Gallardo CA, Chai CN, Chiu L, Yan B, Ding CSL, Yong KJ, Zhou JB, Lee J, Tan K, Ong KH.
7. "The contribution of MYC and PLK1 expression to proliferative capacity in diffuse large B-cell lymphoma" Leukemia & Lymphoma. July 2019. Oon ML, Hoppe MM, Fan SY, Phyu T, Phuong HM, Tan SY, Hue SSS, Wang S, Poon LM, Chan EHL, Lee J, Chee YL, Chng WJ, de Mel S, Liu X, Jeyasekharan AD, Ng SB.
8. "Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphoma" Cancer Medicine, May 2019. Chan EHL, Koh LP, Lee J, de Mel S, Jeyasekharan AD, Liu X, Tang T, Lim ST, Tao M, Quek R, Bin Harunal Ras MF, Lee YS, Diong C, Tan D, Kim SJ, Chee YL, Poon LM.
9. "Preleukemic and second-hit mutational events in an acute myeloid leukaemia patient with a novel germline RUNX1 mutation" Biomarker Research. May 2018. Ng IKS, Lee J, Ng C, Kosmo B, Chiu L, Seah E, Meng M, Mok H, Tan K, Osato M, Chng WJ, Yan B, Tan LK.
10. "Hot in the Tropics" Journal of Hospital Medicine, June 2017. Vidyarthi A.R, Dhaliwal G, Monash B, Shum K.L, Lee J, Zaas A.K.,
